The University Clinical Centre in Gdańsk is the main teaching hospital at the Medical University of Gdańsk. It is a multi-speciality hospital, the largest in the north of Poland and one of the largest in the country.

During the past decade, Uniwersyteckie Centrum Kliniczne conducted 159 clinical trials. In the 10-year time frame, 159 clinical trials started and 78 clinical trials were completed, i.e. on average, 49.1% percent of trials that started reached the finish line to date. In the past 5 years, 95 clinical trials started and 53 clinical trials were completed. i.e. 55.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Uniwersyteckie Centrum Kliniczne" #1 sponsor was "Janssen Research & Development, LLC" with 20 trials, followed by "Pfizer" with 14 trials sponsored, "Takeda" with 13 trials sponsored, "Amgen" with 11 trials sponsored and "Hoffmann-La Roche" with 11 trials sponsored. Other sponsors include 142 different institutions and companies that sponsored additional 91 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Uniwersyteckie Centrum Kliniczne" #1 collaborator was "Eli Lilly and Company" with 8 trials as a collaborator, "Takeda Development Center Americas, Inc." with 5 trials as a collaborator, "Astellas Pharma Inc" with 3 trials as a collaborator, "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 3 trials as a collaborator and "National Center for Research and Development, Poland" with 3 trials as a collaborator. Other collaborators include 48 different institutions and companies that were collaborators in the rest 51 trials.

According to Clinical.Site data, the most researched conditions in "Uniwersyteckie Centrum Kliniczne" are "Carcinoma, Non-Small-Cell Lung" (7 trials), "Chronic Lymphocytic Leukemia" (7 trials), "Multiple Myeloma" (7 trials), "Breast Cancer" (4 trials) and "Cerebral Palsy" (4 trials). Many other conditions were trialed in "Uniwersyteckie Centrum Kliniczne" in a lesser frequency.

Most popular intervention types in "Uniwersyteckie Centrum Kliniczne" are "Drug" (188 trials), "Biological" (23 trials), "Other" (14 trials), "Device" (6 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (61 trials), "Rituximab" (10 trials), "Dexamethasone" (8 trials), "Carboplatin" (7 trials) and "Gemcitabine" (7 trials). Other intervention names were less common.

The vast majority of trials in "Uniwersyteckie Centrum Kliniczne" are 202 trials for "All" genders, 12 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are 102 active trials in "Uniwersyteckie Centrum Kliniczne". 1 are not yet recruiting, 57 are recruiting, 43 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 80 completed trials in Uniwersyteckie Centrum Kliniczne, undefined suspended trials, and 28 terminated clinical trials to date.

Out of the total trials that were conducted in Uniwersyteckie Centrum Kliniczne, 22 "Phase 1" clinical trials were conducted, 61 "Phase 2" clinical trials and 129 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 4 trials that are defined as “Not Applicable".

Uniwersyteckie Centrum Kliniczne has several departments that took part in Clinical trials: "Uniwersyteckie Centrum Kliniczne Klinika Onkologii i Radioterapii" - 41 trials, "Uniwersyteckie Centrum Kliniczne; Klinika Hematologii i Transplantologii" - 35 trials, "Uniwersyteckie Centrum Kliniczne Klinika Dermatologii, Wenerologii i Alergologii" - 3 trials, "Uniwersyteckie Centrum Kliniczne; Klinika Neurologii Rozwojowej" - 6 trials, "Uniwersyteckie Centrum Kliniczne - Dept of Neurology" - 3 trials, "Uniwersyteckie Centrum Kliniczne-Klinika Ginekologii, Ginekologii Onkologicznej i Endokrynologii Gi" - 2 trials, "Uniwersyteckie Centrum Kliniczne Klinika Kardiologii Dziecięcej i Wad Wrodzonych Serca - Site 3604" - 2 trials